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Abstract
Background: Percutaneous coronary intervention (PCI) is one of the most frequently per-
formed cardiac interventions. However, there is limited data regarding the cause of recurrent
hospitalization and repeat revascularization. The aim of this study was to assess re-hospitali-
zation and repeat revascularization within 30 days of the initial hospitalization for PCI, using
data from Opolskie Voivodeship, National Health Fund (NHF) Registry.
Methods: The study population consisted of all PCI patients treated in three interventional
cardiology laboratories in Opolskie Voivodeship in Poland between 1 July 2008 and 30 June
2009. All PCI patients who died during the initial hospitalization or who were transferred to
other units were excluded from the analysis. The study end-point comprised 30 day all-cause
readmission and repeat revascularization.
Results: A total of 2,039 PCI patients were included in the analysis. The all-cause 30-day
readmission rate was 14.6%. The 30-day readmission rate of acute coronary syndrome (ACS)
patients was significantly higher compared to the stable coronary disease patients (ACS 15.8%,
non-ACS 10.7%, p = 0.008). The 30-day readmission rate did not differ between the three
cardiac laboratories. Approximately half (46.2%) of all readmitted patients underwent a repeat
revascularization procedure, mainly in the form of PCI. The overall all-cause 30-day mortality
rate was 0.8%. Compared to the PCI patients who did not require readmission, the readmitted
patients had a significantly higher all-cause 30-day mortality rate (3.6% vs 0.3%, p < 0.001).
Conclusions: Almost one in seven PCI patients requires readmission within 30 days of
hospital discharge. Approximately 50% of all readmitted PCI patients resulted in a repeat
revascularization procedure. PCI patients who were readmitted within 30 days of an index
PCI procedure had a significantly higher all-cause 30-day mortality rate. (Cardiol J 2012; 19,
2: 174–179)
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Introduction
Percutaneous coronary intervention (PCI) is
the most frequently performed cardiac intervention.
Regardless of the epidemiological and outcomes
data of ACS patients in Poland [1], available through
the Polish National Registry of Acute Coronary
Syndrome (PL-ACS) within the POLCARD pro-
gram, the re-hospitalization rate, and the need for
repeat revascularization in patients undergoing PCI,
remains unknown. In 2009, there were a total of
2,636 PCIs performed per 1,000,000 people in Po-
land [2]. However, there is no National Health Fund
(NHF) data on the frequency and cause of repeat
hospitalizations in patients undergoing PCI. Thus,
the objective of our study was to assess the need
for re-hospitalization and repeat revascularization
within the first 30 days after the initial PCI proce-
dure using data from Opolskie Voivodeship, NHF
Registry.
Methods
The study group comprised patients who were
hospitalized and underwent PCI (according to ICD-
-9-CM) in three cardiac laboratories in Opolskie
Voivodeship between 1 July 2008 and 30 June 2009.
We don’t have any detailed information about the
exact time of intervention in patients with acute
coronary syndrome (time from symptom onset and
door-to-balloon time). An invasive strategy was im-
plemented according to guidelines which were in
force at the time of data collection [3, 4]. In case of
ST-segment elevation myocardial infarction
(STEMI), most PCIs were performed within
12 hours from the onset of pain, with time from first
medical contact to balloon inflation less than two
hours, and in case of non-ST-segment elevation
acute coronary syndromes (NSTE-ACS) — within
72 hours. Pharmacological treatment was conduct-
ed according to current guidelines. The dose of as-
pirin in the acute phase was 150–325 mg (300 mg),
the dose of clopidogrel 600 mg or 300 mg in some
cases. Antithrombin therapy and GP IIb/IIIa antago-
nist therapy was conducted according to guidelines
[3, 4]. Practically all patients received angiotensin
converting enzyme inhibitors such as: enalapril,
captopril, perindopril or ramipril; beta-blockers:
bisoprolol, carvedilol, metoprolol or nebivolol and
statins, if  not contraindicated. Patients who had per-
formed PCI received stents in 96% of cases. All PCI
patients who died during the initial hospitalization
or who required transfer to either a higher level of
care or other departments were excluded from the
analysis. The primary end-point comprised all-cause
30-day re-hospitalization, defined as any readmis-
sion within 30 days from the initial hospitalization
discharge date. Post discharge rehabilitation visits
were excluded from the analysis and did not count
as separate re-hospitalizations. The repeat revas-
cularization was examined looking at the need for
subsequent PCI or coronary artery bypass graft
(CABG) surgery. All included patients also had their
30-day all-cause mortality rate examined. Further-
more, the groups of patients who underwent PCI
with an implantation of a drug eluting stent — DES
(E23 according to Diagnosis Related Groups, DRG)
and two or more stents (E24 according to DRG)
were studied. The baseline characteristics and their
impact on measured variables were assessed. Sta-
tistical calculations were carried out using Statisti-
ca ver. 9. A two-tailed p value of < 0.05 was con-
sidered statistically significant.
The study was approved by the local bioethi-
cal committee.
Results
Of 2,039 patients who underwent PCI, 40 pa-
tients who died during the initial hospitalization, and
102 who were transferred to other units, were ex-
cluded from the analysis. The remaining 1,897 PCI
patients (68.2% males; 65.7 years of age [mean])
were included in the analysis (Fig. 1). The overall
all-cause 30-day mortality rate was 0.8%.
The overall readmission rate was 14.6% (n =
= 277), and it differed between the patients with
Figure 1. Patient population.
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various primary diagnoses (Fig. 2). ST-segment ele-
vation myocardial infarction (STEMI), non-ST-seg-
ment elevation myocardial infarction (NSTEMI) and
unstable angina (UA) patients had significantly high-
er readmission rates compared to stable coronary
artery disease (CAD) patients (ACS 15.8% vs non-
-ACS 10.7%, p = 0.008). Most of the studied pa-
tients were re-hospitalized once (68.6%). Conse-
quent rehabilitation as a continuation of treatment
after an index hospitalization was not counted as
a re-hospitalization (575 patients).
Congestive heart failure (CHF) and chronic
renal insufficiency were significantly associated
with a greater readmission rate, as well as age. Pa-
tients with atrial fibrillation, atrio-ventricular conduc-
tion abnormalities, diabetes or peripheral artery
disease, and women, were also shown to have high-
er readmission rates (Tables 1, 2). Importantly,
readmitted patients had significantly higher morta-
lity rates (3.6% vs 0.3%, p < 0.001).
The consequent re-hospitalization was strongly
associated with a repeat revascularization (46.2%,
n = 128) — staged PCI 35.0% vs PCI in acute MI
10.5% vs CABG 0.7%. Staged PCI was performed
most frequently in STEMI patients. However,
NSTEMI and UA patients were at highest risk for
a repeat revascularization due to an acute cardiac
event (Fig. 3).
Based on follow-up records, we analyzed the
survival rates in the participating cardiac laborato-
ries (Kaplan-Meier analysis). The 30-day readmis-
sion rate did not significantly differ (Opole vs both
Nysa and Kędzierzyn-Koźle: 14.3% vs 15.1%, p =
= 0.61) (Fig. 4, Table 3).
Compared to the Opole Medical Center, the
smaller centers had significantly higher repeat revas-
cularization rates in acute MI. Staged PCI was most
frequent in the Opole Medical Center. Importantly,
patients’ baseline characteristics differed between
the participating medical centers: patients admitted
to the Opole Medical Center were more likely to be
diagnosed with an acute STEMI (Table 3).
The reasons for hospital readmissions varied;
the leading reasons were cardiac problems (79.4%),
Table 1. Re-hospitalization and 30-day all-cause mortality.
Readmitted group (n = 277) No readmission group (n = 1,620) P
Male 66.1% (n = 183) 68.5% (n = 1,110) 0.42
Female 33.9% (n = 94) 31.5% (n = 510) 0.42
Age [years] 67.5 65.3 0.0014
Diabetes 32.5% (n = 90) 28.1% (n = 456) 0.14
Congestive heart failure 27.8% (n = 77) 18.6% (n = 301) < 0.001
Chronic renal insufficiency 9.4% (n = 26) 4.6% (n = 74) < 0.001
Hypertension 75.1% (n = 208) 76.8% (n = 1,244) 0.54
Peripheral artery disease 29.2% (n = 81) 25.6% (n = 414) 0.20
Bradyarrhythmia 6.1% (n = 17) 4.4% (n = 71) 0.20
Atrial fibrillation 11.6% (n = 32) 8.3% (n = 134) 0.07
Cardiac arrest 1.4% (n = 4) 1.1% (n = 18) 0.63
PCI with DES 10.5% (n = 29) 10.8% (n = 175) 0.87
PCI ≥ 2 stents or multivessel 2.5% (n = 7) 3.3% (n = 54) 0.48
30-day mortality 3.6% (n = 10) 0.3% (n = 5) < 0.001
DES — drug-eluting stent; PCI — percutaneous coronary intervention
Figure 2. Readmission and primary clinical diagnosis;
STEMI — ST-segment elevation myocardial infarction;
NSTEMI — non-ST-segment elevation myocardial in-
farction; UA — unstable angina; CAD — stable coronary
artery disease.
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followed by gastrointestinal (5.1%), cerebrovascu-
lar (2.2%), cancer (2.2%), diabetes and its compli-
cations (1.8%), respiratory (1.4%), renal insufficien-
cy (1.1%) and others (6.9%). Of all the readmitted
patients, patients with stable coronary disease ac-
counted for 44.4%, MI and UA — 18.8%, CHF —
9.0%, cardiac arrhythmias — 2.9%, cardiac arrest
— 0.4% and others, such as structural heart disease
and hypertension, 4.0%.
Discussion
Of all PCI patients, one in seven required
a repeat hospitalization within 30 days of discharge.
Approximately 50% of all readmitted PCI patients
underwent a repeat revascularization procedure.
PCI patients who were readmitted within 30 days
of an index PCI procedure had a significantly high-
er all-cause 30-day mortality rate. Curtis et al. [5]
reported a 14.6% rate of 30-day readmission based
on their analysis of 315,241 patients aged 65 and
older who underwent PCI in 1,108 invasive cardiology
Table 2. Multivariate logistic regression analysis of factors predicting readmission.
Factor Odds ratio 95% CI P
Gender 1.02 0.77   1.35 0.89
Age 1.01 1.00   1.03 0.04
Diabetes 1.12 0.84   1.49 0.44
Congestive heart failure 1.52 1.10   2.09 0.01
Chronic renal insufficiency 1.70 1.04   2.79 0.03
Hypertension 0.85 0.62   1.15 0.29
Peripheral artery disease 0.91 0.66   1.26 0.59
Bradyarrhythmia 1.10 0.62   1.95 0.74
Atrial fibrillation 1.16 0.75   1.78 0.50
Cardiac arrest 1.40 0.46   4.26 0.55
PCI with DES 0.96 0.63   1.47 0.85
PCI ≥ 2 stents or multivessel 0.75 0.34   1.69 0.49
CI — confidence interval; DES — drug-eluting stent; PCI — percutaneous coronary intervention
Figure 3. Cause of repeat revascularization (staged, in
acute coronary syndromes) and 30-day re-hospitaliza-
tion; PCI — percutaneous coronary intervention; ACS —
acute coronary syndrome; MI — myocardial infarction;
rest abbreviations as in Figure 2.
Figure 4. Kaplan-Meier survival analysis in the partici-
pating medical centers.
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Table 3. Comparison of participating medical centers.
Opole (n = 1,217) Kędzierzyn-Koźle and Nysa (n = 680) P
Primary clinical diagnosis
STEMI 37.8% (n = 460) 24.3% (n = 165) < 0.001
NSTEMI 25.4% (n = 309) 27.6% (n = 188) 0.28
UA 15.4% (n = 188) 21.5% (n = 146) < 0.001
Stable coronary disease 21.3% (n = 259) 26.6% (n = 181) 0.008
Rehospitalization 14.3% (n = 174) 15.1% (n = 103) 0.61
Repeat revascularization 42.0% (n = 73) 53.4% (n = 55) 0.06
PCI for MI* 9.6% (n = 7) 40.0% (n = 22) < 0.001
Other reasons 58.0% (n = 101) 46.6% (n = 48) 0.06
*Percentage of total repeat revascularization number; abbreviations as in Figures 2 and 3
centers in the USA in 2005. The reported repeat re-
vascularization rate was 27.5%. The readmission
rate ranged from 8.9% to 22% between hospitals,
and was significantly higher in patients with acute
MI than in non-acute MI patients (17.5% vs 13.6%).
It appears that early re-hospitalization is asso-
ciated with coexisting cardiac conditions. On the
contrary, the 30-day readmission rate could be
a function of the quality of in-hospital and early post
discharge care; however, the results need to be
confirmed by larger studies. The reported one-year
readmission rate of patients undergoing PCI rang-
es between 29–31% in the United States [6].
Based on the 2009 data, there were 2,636 PCIs
performed for every million people in Poland, while
the overall mean in Opolskie Voivodeship was 2,916
PCIs/1,000,000 [2]. There were three 24/7 cardio-
logy laboratories in this region which participated
in the study. Compared to the lower volume cen-
ters, i.e. Nysa and Kędzierzyn-Koźle, where most
of the UA and stable coronary disease patients were
referred to hospital, hospitalizations of STEMI pa-
tients were more common at the Medical Center
in Opole. The discussed difference could be caused
by the longer-established nature and better relation-
ship with referring facilities of the Medical Center
in Opole. The 30-day readmission rate did not dif-
fer between the Medical Center in Opole and the
other participating hospitals with lower overall PCI
volume. There were differences in repeat revascu-
larization rates, in particular in patients presenting
with an acute MI. The observed pattern could be
due to the fact that the reference centers tend to
receive sicker patients. On the other hand, the big-
ger centers focus on long-term care including
staged PCI procedures, frequently scheduled at the
time of an initial visit.
The reasons for readmission after PCI can be
categorized into several groups, such as procedur-
al complications (bleeding, coronary vessel occlu-
sion, contrast induced nephropathy), planned revas-
cularization and consequences of coexisting diseas-
es and risk factors. Cardiac problems were the
commonest cause of readmissions in the study
group (79.4%). One of the limitations of the paper
is that the data about acute complications after PCI
was not analyzed.
Patients who had a PCI performed received
stents in 96% of cases. The number of PCIs with
DES implantation may appear to be low, but the
strategy was that drug-eluting stents were used
mainly during staged procedure at that time and
bare-metal stents were used practically in all pa-
tients with myocardial infarction. The limitations of
the study included a lack of detailed information of
the initial procedure (e.g. number of stents) which
could have played an important role in the success
of the treatment provided. The percentage of pa-
tients treated with GP IIb/IIIa inhibitors wasn’t es-
timated. The remaining coronary vessel characte-
ristics have not been analyzed further; we did not
examine whether or not the repeat revasculariza-
tion was performed in the same vessel (including
in-stent restenosis etc.).
It is also impossible to determine whether the
initial intervention was a staged PCI procedure for
a multivessel CAD. Such information could have
helped in explaining a surprisingly high repeat re-
vascularization rate in acute MI patients who pre-
sented initially with NSTEMI and UA. An increased
rate of repeated revascularization in acute MI pa-
tients in this group could be explained by an inade-
quate and difficult recognition of a culprit lesion in
patients with multivessel CAD. Compared to the
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acute MI patients who underwent PCI only in the
culprit lesion, the acute MI patients who underwent
complete revascularization had significantly lower
MI and repeat revascularization rate during the two
years of follow-up [7].
It has been reported that improved quality of
PCI and post PCI care is associated with better clini-
cal outcomes, including fewer complications and
lower rates of the composite end-point consisting
of death, cardiovascular accidents and repeat revas-
cularization [8]. Furthermore, the lower re-hospi-
talization rate of CHF patients has been described
in patients who received specialized treatment and
were followed closely after discharge [9]. There are
also other essential components in patients under-
going PCI, such as an institutional profile of the
healthcare system, quality of the in-hospital and
post-discharge care, as well as the aspect of com-
pliance with post-discharge antiplatelet medication
regimen. The presented outcomes require a long-
-term observation to determine the best solution
to reduce the re-hospitalization rate and, conse-
quently, the cost of medical care.
Conclusions
The readmission rate was highest in patients
who presented initially with STEMI, and lowest in
patients with stable CAD. The readmitted patients
were more likely to be elderly and female. The
planned revascularization was performed most fre-
quently in patients with STEMI as an initial presen-
tation. The NSTEMI and UA patients were required
to undergo repeat revascularization most frequently
for acute MI. Readmission rates were comparable
between the participating hospitals. The indepen-
dent predictors of increased risk of re-hospitaliza-
tion were: coexistent CHF, chronic renal failure,
and older age.
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